123 related articles for article (PubMed ID: 1970139)
1. Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects.
Bakshi R; Faden AI
Neurosci Lett; 1990 Mar; 110(1-2):113-7. PubMed ID: 1970139
[TBL] [Abstract][Full Text] [Related]
2. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
3. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis.
Bakshi R; Faden AI
Brain Res; 1990 Jan; 507(1):1-5. PubMed ID: 1967971
[TBL] [Abstract][Full Text] [Related]
4. Glycine reverses 7-chlorokynurenic acid-induced inhibition of [3H]MK-801 binding.
Sircar R; Frusciante MJ; Javitt DC; Zukin SR
Brain Res; 1989 Dec; 504(2):325-7. PubMed ID: 2557130
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
Hauser KF; Foldes JK; Turbek CS
Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
[TBL] [Abstract][Full Text] [Related]
6. Glycine site associated with the NMDA receptor modulates long-term potentiation.
Oliver MW; Kessler M; Larson J; Schottler F; Lynch G
Synapse; 1990; 5(4):265-70. PubMed ID: 2163119
[TBL] [Abstract][Full Text] [Related]
7. Modulation of N-methyl-D-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones.
Vyklický L; Benveniste M; Mayer ML
J Physiol; 1990 Sep; 428():313-31. PubMed ID: 2172523
[TBL] [Abstract][Full Text] [Related]
8. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
Danysz W; Fadda E; Wroblewski JT; Costa E
Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
[TBL] [Abstract][Full Text] [Related]
9. In vivo modulation of N-methyl-D-aspartate receptor-dependent long-term potentiation by the glycine modulatory site.
Thiels E; Weisz DJ; Berger TW
Neuroscience; 1992; 46(3):501-9. PubMed ID: 1347648
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons.
Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF
J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388
[TBL] [Abstract][Full Text] [Related]
11. Schild plot analysis of glycine and kynurenic acid at the N-methyl-D-aspartate excitatory amino acid receptor.
Pullan LM; Cler JA
Brain Res; 1989 Sep; 497(1):59-63. PubMed ID: 2551451
[TBL] [Abstract][Full Text] [Related]
12. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
Long JB; Skolnick P
Eur J Pharmacol; 1994 Aug; 261(3):295-301. PubMed ID: 7813551
[TBL] [Abstract][Full Text] [Related]
13. The glycine site of the N-methyl-D-aspartate receptor channel: differences between the binding of HA-966 and of 7-chlorokynurenic acid.
Kloog Y; Lamdani-Itkin H; Sokolovsky M
J Neurochem; 1990 May; 54(5):1576-83. PubMed ID: 1691278
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations.
Zhang L; Peoples RW; Oz M; Harvey-White J; Weight FF; Brauneis U
J Neurophysiol; 1997 Aug; 78(2):582-90. PubMed ID: 9307096
[TBL] [Abstract][Full Text] [Related]
15. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
Singh L; Oles RJ; Tricklebank MD
Br J Pharmacol; 1990 Feb; 99(2):285-8. PubMed ID: 1691674
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
Kleckner NW; Dingledine R
Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
[TBL] [Abstract][Full Text] [Related]
18. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.
Kemp JA; Foster AC; Leeson PD; Priestley T; Tridgett R; Iversen LL; Woodruff GN
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6547-50. PubMed ID: 2842779
[TBL] [Abstract][Full Text] [Related]
19. A glycine antagonist reduces ischemia-induced CA1 cell loss in vivo.
Wood ER; Bussey TJ; Phillips AG
Neurosci Lett; 1992 Sep; 145(1):10-4. PubMed ID: 1334240
[TBL] [Abstract][Full Text] [Related]
20. The glycine site modulates NMDA-mediated changes of intracellular free calcium in cultures of hippocampal neurons.
Oliver MW; Shacklock JA; Kessler M; Lynch G; Baimbridge KG
Neurosci Lett; 1990 Jul; 114(2):197-202. PubMed ID: 1975660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
